SHINIL PHARMACEUTICAL CO., LTD. financial statements, including revenue, expenses, profit, and loss
The total revenue of 012790 for the last quarter is 20.63 B KRW, and it's 15.81% lower compared to the previous quarter. The net income of Q3 24 is 2.77 B KRW.